Terms: = Ovarian cancer AND FAM131B, Q86XD5, KIAA0773, 9715 AND Treatment
1 results:
1. Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer.
Liu Y; Ren Z; Xu S; Bai H; Ma N; Wang F
Cancer Chemother Pharmacol; 2015 Mar; 75(3):645-51. PubMed ID: 25599660
[TBL] [Abstract] [Full Text] [Related]
